Pancreatic Ductal Adenocarcinoma Latest Advances

ASO Visual Abstract: Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surgery: Local Therapies are Associated with Longer Survival in Selected Cases: A Systematic Review and Meta-Analysis.

Journal: Annals of surgical oncology

Published: June 17, 2026

Daraxonrasib effective in metastatic pancreatic ductal adenocarcinoma.

Journal: Nature reviews. Clinical oncology

Published: June 12, 2026

microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6 [Retraction].

Journal: American journal of cancer research

Published: June 10, 2026

The regulatory roles of non-coding RNAs in aerobic glycolysis and therapeutic potential in pancreatic ductal adenocarcinoma.

Journal: Annals of medicine

Published: June 09, 2026

Glypican-1 targeted nanoplatform for pancreatic ductal adenocarcinoma: interpreting findings.

Journal: Journal of cancer research and clinical oncology

Published: June 07, 2026

CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinoma.

Journal: bioRxiv : the preprint server for biology

Published: June 05, 2026

GATA4 loss promotes mutant Kras -driven pancreatic ductal adenocarcinoma in the absence of canonical precursor lesions.

Journal: bioRxiv : the preprint server for biology

Published: June 05, 2026

ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time Bias on Survival.

Journal: Annals of surgical oncology

Published: June 02, 2026

ASO Visual Abstract: Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: a Comparative Study with Pancreatic Ductal Adenocarcinoma.

Journal: Annals of surgical oncology

Published: June 01, 2026

Progressive CA19-9 elevation with normal bilirubin as an escalation signal in pseudocyst-like pancreatic ductal adenocarcinoma.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: June 01, 2026

PLGA/PVA nanoparticles to deliver a protein-based cancer vaccine targeting GPC1 for the treatment of pancreatic ductal adenocarcinoma.

Journal: Nanomedicine (London, England)

Published: May 25, 2026

Para-aortic lymph nodes in oligometastatic pancreatic ductal adenocarcinoma - Authors' reply.

Journal: The Lancet. Oncology

Published: May 17, 2026

Pancreatic Ductal Adenocarcinoma Latest Advances

Find the Latest Research About Pancreatic Ductal Adenocarcinoma

ASO Visual Abstract: Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surgery: Local Therapies are Associated with Longer Survival in Selected Cases: A Systematic Review and Meta-Analysis.

ASO Visual Abstract: Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surgery: Local Therapies are Associated with Longer Survival in Selected Cases: A Systematic Review and Meta-Analysis.

Daraxonrasib effective in metastatic pancreatic ductal adenocarcinoma.

Daraxonrasib effective in metastatic pancreatic ductal adenocarcinoma.

microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6 [Retraction].

microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6 [Retraction].

The regulatory roles of non-coding RNAs in aerobic glycolysis and therapeutic potential in pancreatic ductal adenocarcinoma.

The regulatory roles of non-coding RNAs in aerobic glycolysis and therapeutic potential in pancreatic ductal adenocarcinoma.

Glypican-1 targeted nanoplatform for pancreatic ductal adenocarcinoma: interpreting findings.

Glypican-1 targeted nanoplatform for pancreatic ductal adenocarcinoma: interpreting findings.

CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinoma.

CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinoma.

GATA4 loss promotes mutant Kras -driven pancreatic ductal adenocarcinoma in the absence of canonical precursor lesions.

GATA4 loss promotes mutant Kras -driven pancreatic ductal adenocarcinoma in the absence of canonical precursor lesions.

ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time Bias on Survival.

ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time Bias on Survival.

ASO Visual Abstract: Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: a Comparative Study with Pancreatic Ductal Adenocarcinoma.

ASO Visual Abstract: Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: a Comparative Study with Pancreatic Ductal Adenocarcinoma.

Progressive CA19-9 elevation with normal bilirubin as an escalation signal in pseudocyst-like pancreatic ductal adenocarcinoma.

Progressive CA19-9 elevation with normal bilirubin as an escalation signal in pseudocyst-like pancreatic ductal adenocarcinoma.

PLGA/PVA nanoparticles to deliver a protein-based cancer vaccine targeting GPC1 for the treatment of pancreatic ductal adenocarcinoma.

PLGA/PVA nanoparticles to deliver a protein-based cancer vaccine targeting GPC1 for the treatment of pancreatic ductal adenocarcinoma.

Para-aortic lymph nodes in oligometastatic pancreatic ductal adenocarcinoma - Authors' reply.

Para-aortic lymph nodes in oligometastatic pancreatic ductal adenocarcinoma - Authors' reply.